D. C. , office filed a statement of interest[1] in a relator's action, arguing that "[c]onduct giving rise to a regulatory violation can also give rise to" False Claims Act liability. [2]The case is U. S. ex rel. Patricia Crocano v. Trividia Health Inc. , before the U. S. District Court for the Southern District of Florida. Specifically, the DOJ requested "that the ruling not foreclose the possibility that, under certain circumstances," conduct that violates the Federal Food, Drug and Cosmetic Act or U. S. Food and Drug Administration regulations "could be material to the government's payment. . .

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

• Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
• Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
• Create custom alerts for specific article and case topics and so much more!

Read Full Story: https://www.law360.com/articles/1522541/doj-filing-reawakens-fraud-on-the-fda...